Article
In celebration of Ruggero Ceppellini: HLA in transplantation.
HLA - 1 Feb 2017
Petersdorf E W
Abstract excerpt
The availability of hematopoietic cell transplantation as curative therapy for blood disorders has been dramatically improved through a better understanding of the human leukocyte antigen (HLA) barrier. Although a fully compatible unrelated donor is preferable, transplantation from donors with a limited degree of HLA mismatching is associated with acceptable outcomes in many cases. Research on the limits of HLA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.